Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors
D Patel, D Chan, G Cehic, N Pavlakis… - Expert Review of …, 2016 - Taylor & Francis
Introduction: Neuroendocrine tumors are a heterogeneous group of malignancies,
characterised by production of hormones and vasoactive peptides. The incidence of …
characterised by production of hormones and vasoactive peptides. The incidence of …
[PDF][PDF] Diagnosis and management of type III gastric neuroendocrine tumor: Recent advances
TM Le, JW Cho - Gastroenterol Res Pract, 2024 - jjgastro.com
Abstract Gastric Neuroendocrine Tumors (NETs) encompass a heterogeneous group of
neoplasms arising from enterochromaffin-like cells in the gastric mucosa. Among the various …
neoplasms arising from enterochromaffin-like cells in the gastric mucosa. Among the various …
The clinical significance of hormone-naïve prostatic adenocarcinoma with neuroendocrine differentiation: A histopathological and epidemiological re-evaluation
A Kannan - 2022 - bridges.monash.edu
There are effective treatments for patients with localised prostate cancer, yet some fail
treatment and experience disease progression. Some progress slowly while others progress …
treatment and experience disease progression. Some progress slowly while others progress …
[HTML][HTML] Applying the use of novel biomarkers for neuroendocrine tumors in the clinic: where are we now?
K Daskalakis, O Norlén, P Hellman… - International Journal of …, 2019 - Taylor & Francis
Neuroendocrine tumors (NETs) arise from the diffuse neuroendocrine system and
demonstrate a great diversity in their clinical course with unpredictable and variable …
demonstrate a great diversity in their clinical course with unpredictable and variable …
Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study
三森友靖， ミモリトモヤス - 2022 - jair.repo.nii.ac.jp
Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective
Analysis from the NEJ023 Study Page 1 Citation: Mimori, T.; Shukuya, T.; Ko, R.; Okuma, Y.; …
Analysis from the NEJ023 Study Page 1 Citation: Mimori, T.; Shukuya, T.; Ko, R.; Okuma, Y.; …
[PDF][PDF] Review of treatment options of psychiatric symptoms in a case of functional neuroendocrine tumor
PS Bardoloi - J Neurooncol Neurscience, 2018 - researchgate.net
Neuroendocrine tumors (NET) are tumors arising from neuroendocrine cells in the body and
are found in the gastrointestinal tract, and less commonly pancreas, lungs, thymus and …
are found in the gastrointestinal tract, and less commonly pancreas, lungs, thymus and …
Update on Histological Reporting Changes in Neuroendocrine Neoplasms
B Konstantin, A Rodriguez-Calero… - Current Oncology …, 2021 - search.proquest.com
The heterogeneity of NEN regarding the organ of origin, differentiation and molecular
subtypes make development of personalised therapy a challenge needing more …
subtypes make development of personalised therapy a challenge needing more …
[引用][C] Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
LJS Leeuwaarde, MR Vriens, HM Wieke, MET Verbeek… - … SURVEILLANCE STRATEGIES IN …
Insulinoma-Associated Protein 1 (INSM1) as a Novel Immunohistochemical Marker for Neuroendocrine Neoplasms
HA IBRAHIM, ABDELK DALIA… - The Medical Journal of …, 2021 - mjcu.journals.ekb.eg
Background: Diagnosis of neuroendocrine differentiation is important for tumor classification
in different body systems. Confirmation of neuroendocrine differentiation, sometimes require …
in different body systems. Confirmation of neuroendocrine differentiation, sometimes require …
Role of the ratio of NSE serum concentration in evaluating the therapeutic effect on metastatic neuroendocrine neoplasms of the liver
J Kan, Y Tian, Y Shao, H Xu, X Li, Q Tang - Tumori Journal, 2022 - journals.sagepub.com
Background: Neuron-specific enolase (NSE) is one of the biomarkers of neuroendocrine
neoplasms (NEN). Its level of evidence is significantly lower than some other biomarkers …
neoplasms (NEN). Its level of evidence is significantly lower than some other biomarkers …